ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2022

Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk.

Robert F Hillary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.